Hybrid Ablation of the Atrial Fibrillation
A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Electrophysiology and Cardiovascular Physiology".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 374
Special Issue Editor
Interests: interventional cardiology; electrophysiology; arrhythmias
Special Issue Information
Dear colleague,
Atrial fibrillation is the most frequent supraventricular arrhythmia in clinical practice. The therapeutic approach is generally directed to restore, when possible, normal heart rhythm and prevent related thromboembolic phenomena; however, clinical scenarios can be very complex and therefore require a multidisciplinary strategy.
The AF Heart Team proposed in the ESC 2024 guidelines is a team composed of a clinical cardiologist, an electrophysiologist, and a cardiac surgeon who collaborate and try to propose the best therapeutic strategy to the patient. Hybrid ablation of atrial fibrillation is an innovative therapeutic opportunity for the patient that aims to overcome the limitations of transcatheter ablation alone or surgical ablation alone. The purpose of this Special Issue is to deepen the subject considering rationale, techniques, results, complications, and future prospectives.
I would like to invite you to submit a paper to this Special Issue. Considering your expertise in the topic, I would be grateful if you could contribute one or two papers. I believe it is very important to promote knowledge of the hybrid ablation procedure for the treatment of atrial fibrillation considering the publication of the latest ESC guidelines and dedicated trials.
Dr. Massimiliano Marini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- ablation
- hybrid ablation
- techniques
- videothoracoscopic approach
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
